Identifying risk factors for COVID-19 transmission in communities and workplaces
Official title: Risk Factors for Community- and Workplace Transmission of COVID-19
Run by Oslo University Hospital · NCT04320732 · Data updated 2026-11-12
This study is trying to find out what factors help spread COVID-19 in communities and workplaces by asking questions to people who have had the virus, healthcare workers, and healthy volunteers.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250000 (estimated) |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Status | Recruiting |
| Started | March 27, 2020 |
| Main results expected | March 27, 2025 |
| Study ends | March 20, 2030 |
| Registry record updated | December 13, 2021 |
| Trial ID | NCT04320732 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Norwegian adults, including those diagnosed with COVID-19 and healthcare workers.
✕Probably not a fit
Patients who are unable to provide consent will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify real-life risk factors associated with COVID-19 transmission through an electronic questionnaire. Participants will include hospitalized and non-hospitalized COVID-19 patients, healthcare personnel, and healthy volunteers. The study will utilize a web-based platform for data collection and consent, ensuring compliance with GDPR regulations. By analyzing the collected data, the study seeks to inform targeted public health measures to mitigate the spread of the virus.
Why it matters
Potential benefit: If successful, this study could provide critical insights that help reduce COVID-19 transmission rates in communities and workplaces.
How similar studies have gone: Other studies have successfully identified risk factors for COVID-19 transmission, making this approach both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Norwegian adult Exclusion Criteria: * Unable to consent
Where it's running
-
Oslo University Hospital
Oslo, Norway Recruiting
Study contacts
- Study coordinator: Arne Søraas, MD, PhD
- Email: Arne.Vasli.Lund.Soraas@rr-research.no
- Phone: +4790652904
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Testing a new method to detect COVID-19 using exhaled air
This study is testing a new breath test for COVID-19 to see if it works as well as the traditional nose swab method, especially for people showing symptoms or who have been around someone infected.
-
Aerosol box use during cardiopulmonary arrest
This project tests whether using an aerosol box during emergency airway procedures and chest compressions lowers particle spread and is practical for healthcare teams treating cardiac arrest patients, including those with COVID-19.
-
Using digital devices to monitor respiratory virus infections
This study is testing whether wearable devices like smartwatches can help track health changes in people with respiratory virus infections to better understand how severe the illness might be.
-
COVID-19 antibody testing and mental health assessment among healthcare workers
This study is testing how many healthcare workers at NewYork-Presbyterian Hospital have COVID-19 antibodies and how knowing their antibody status affects their mental health and coping during the pandemic.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.